About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Proteomics - Clinical Applications
›
top-articles
Proteomics - Clinical Applications
1.5
(top 50%)
impact factor
1.4K
(top 20%)
papers
29.3K
(top 10%)
citations
64
(top 10%)
h
-index
1.5
(top 50%)
impact factor
2.2K
all documents
31.2K
doc citations
101
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Exosomes in bodily fluids are a highly stable resource of disease biomarkers
Proteomics - Clinical Applications
2015
426
2
Oligodendrocytes secrete exosomes containing major myelin and stress‐protective proteins: Trophic support for axons?
Proteomics - Clinical Applications
2007
423
3
Trans‐Proteomic Pipeline, a standardized data processing pipeline for large‐scale reproducible proteomics informatics
Proteomics - Clinical Applications
2015
319
4
Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy
Proteomics - Clinical Applications
2014
311
5
ELISA in the multiplex era: Potentials and pitfalls
Proteomics - Clinical Applications
2015
288
6
Cathepsin B: Multiple roles in cancer
Proteomics - Clinical Applications
2014
285
7
Clinical proteomics: A need to define the field and to begin to set adequate standards
Proteomics - Clinical Applications
2007
274
8
Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders
Proteomics - Clinical Applications
2012
271
9
The pig as an animal model for human pathologies: A proteomics perspective
Proteomics - Clinical Applications
2014
213
10
Systematic comparison of the human saliva and plasma proteomes
Proteomics - Clinical Applications
2009
186
11
The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline
Proteomics - Clinical Applications
2008
182
12
Using data‐independent, high‐resolution mass spectrometry in protein biomarker research: Perspectives and clinical applications
Proteomics - Clinical Applications
2015
182
13
CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics
Proteomics - Clinical Applications
2008
178
14
Identification of gene products present in Triton X-100 soluble and insoluble fractions of human spermatozoa lysates using LC-MS/MS analysis
Proteomics - Clinical Applications
2007
176
15
Redox proteomics identification of 4‐hydroxynonenal‐modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis
Proteomics - Clinical Applications
2009
172
16
Microfiltration isolation of human urinary exosomes for characterization by MS
Proteomics - Clinical Applications
2010
170
17
Investigation of an albumin-enriched fraction of human serum and its albuminome
Proteomics - Clinical Applications
2007
165
18
Aptamers and the next generation of diagnostic reagents
Proteomics - Clinical Applications
2012
163
19
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis
Proteomics - Clinical Applications
2010
139
20
Discovery and validation of urinary biomarkers for prostate cancer
Proteomics - Clinical Applications
2008
133
21
T
n and sialyl‐Tn antigens, aberrant
O
‐glycomics as human disease markers
Proteomics - Clinical Applications
2013
131
22
Proteomic workflow for analysis of archival formalin‐fixed and paraffin‐embedded clinical samples to a depth of 10 000 proteins
Proteomics - Clinical Applications
2013
131
23
Urine proteomics for profiling of human disease using high accuracy mass spectrometry
Proteomics - Clinical Applications
2009
117
24
Candidate biomarkers in exosome‐like vesicles purified from rat and mouse urine samples
Proteomics - Clinical Applications
2010
116
25
Glycosylation of liver acute‐phase proteins in pancreatic cancer and chronic pancreatitis
Proteomics - Clinical Applications
2010
115
26
Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF
Proteomics - Clinical Applications
2015
113
27
Biomarker discovery in mass spectrometry‐based urinary proteomics
Proteomics - Clinical Applications
2016
110
28
Shotgun proteomics identifies proteins specific for acute renal transplant rejection
Proteomics - Clinical Applications
2010
105
29
Human urinary peptide database for multiple disease biomarker discovery
Proteomics - Clinical Applications
2011
105
30
MALDI‐TOF MS: an upcoming tool for rapid detection of antibiotic resistance in microorganisms
Proteomics - Clinical Applications
2013
105
31
Characterisation of flucloxacillin and 5‐hydroxymethyl flucloxacillin haptenated HSA
in vitro
and
in vivo
Proteomics - Clinical Applications
2009
101
32
Proteomic profiling of Gram‐negative bacterial outer membrane vesicles: Current perspectives
Proteomics - Clinical Applications
2016
101
33
Recent development of mass spectrometry and proteomics applications in identification and typing of bacteria
Proteomics - Clinical Applications
2016
99
34
Quantification of decellularized human myocardial matrix: A comparison of six patients
Proteomics - Clinical Applications
2016
97
35
Body fluid proteomics: Prospects for biomarker discovery
Proteomics - Clinical Applications
2007
91
36
Glycoproteomics and clinical applications
Proteomics - Clinical Applications
2010
91
37
State of the art of 2D DIGE
Proteomics - Clinical Applications
2015
90
38
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers
Proteomics - Clinical Applications
2008
88
39
CE‐MS in biomarker discovery, validation, and clinical application
Proteomics - Clinical Applications
2011
88
40
The Case for Proteomics and Phospho‐Proteomics in Personalized Cancer Medicine
Proteomics - Clinical Applications
2019
88
41
A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease
Proteomics - Clinical Applications
2018
87
42
Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid
Proteomics - Clinical Applications
2011
86
43
Exploring the human tear fluid:
D
iscovery of new biomarkers in multiple sclerosis
Proteomics - Clinical Applications
2014
85
44
Multiplex assays for biomarker research and clinical application: Translational science coming of age
Proteomics - Clinical Applications
2010
83
45
Unraveling the molecular repertoire of tears as a source of biomarkers: Beyond ocular diseases
Proteomics - Clinical Applications
2015
82
46
Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease
Proteomics - Clinical Applications
2019
82
47
Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies
Proteomics - Clinical Applications
2007
80
48
Abnormal pathways in the genu of the corpus callosum in schizophrenia pathogenesis: a proteome study
Proteomics - Clinical Applications
2007
80
49
Reconstruction of a robust glycodiagnostic agent supported by multiple lectin‐assisted glycan profiling
Proteomics - Clinical Applications
2013
80
50
Tissue is alive: New technologies are needed to address the problems of protein biomarker pre‐analytical variability
Proteomics - Clinical Applications
2009
79
site/software ©
exaly
; All materials licenced under
CC by-SA
.